Annual CFO
-$134.68 M
-$42.50 M-46.10%
December 1, 2024
Summary
- As of March 12, 2025, VERA annual cash flow from operations is -$134.68 million, with the most recent change of -$42.50 million (-46.10%) on December 1, 2024.
- During the last 3 years, VERA annual CFO has fallen by -$110.97 million (-468.07%).
- VERA annual CFO is now -1208.96% below its all-time high of -$10.29 million, reached on December 31, 2019.
Performance
VERA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$39.18 M
-$2.30 M-6.23%
December 1, 2024
Summary
- As of March 12, 2025, VERA quarterly cash flow from operations is -$39.18 million, with the most recent change of -$2.30 million (-6.23%) on December 1, 2024.
- Over the past year, VERA quarterly CFO has stayed the same.
- VERA quarterly CFO is now -1599.87% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
VERA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$134.68 M
-$14.04 M-11.64%
December 1, 2024
Summary
- As of March 12, 2025, VERA TTM cash flow from operations is -$134.68 million, with the most recent change of -$14.04 million (-11.64%) on December 1, 2024.
- Over the past year, VERA TTM CFO has stayed the same.
- VERA TTM CFO is now -5742.91% below its all-time high of -$2.31 million, reached on March 31, 2020.
Performance
VERA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VERA Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -46.1% | 0.0% | 0.0% |
3 y3 years | -468.1% | 0.0% | 0.0% |
5 y5 years | -1209.0% | 0.0% | 0.0% |
VERA Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -468.1% | at low | -508.6% | at low | -468.1% | at low |
5 y | 5-year | -1209.0% | at low | -1599.9% | at low | -5742.9% | at low |
alltime | all time | -1209.0% | at low | -1599.9% | at low | -5742.9% | at low |
Vera Therapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$134.68 M(+46.1%) | -$39.18 M(+6.2%) | -$134.68 M(+11.6%) |
Sep 2024 | - | -$36.88 M(+48.8%) | -$120.64 M(+13.0%) |
Jun 2024 | - | -$24.78 M(-26.7%) | -$106.73 M(+7.0%) |
Mar 2024 | - | -$33.83 M(+34.5%) | -$99.72 M(+8.2%) |
Dec 2023 | -$92.18 M(+36.4%) | -$25.14 M(+9.5%) | -$92.18 M(+4.5%) |
Sep 2023 | - | -$22.97 M(+29.3%) | -$88.20 M(+5.4%) |
Jun 2023 | - | -$17.77 M(-32.4%) | -$83.65 M(-1.5%) |
Mar 2023 | - | -$26.29 M(+24.2%) | -$84.91 M(+25.6%) |
Dec 2022 | -$67.60 M | -$21.16 M(+14.9%) | -$67.60 M(+27.8%) |
Sep 2022 | - | -$18.42 M(-3.2%) | -$52.87 M(+32.4%) |
Jun 2022 | - | -$19.03 M(+111.9%) | -$39.94 M(+39.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$8.98 M(+39.5%) | -$28.57 M(+20.5%) |
Dec 2021 | -$23.71 M(-31.9%) | -$6.44 M(+17.4%) | -$23.71 M(-46.9%) |
Sep 2021 | - | -$5.48 M(-28.5%) | -$44.65 M(+7.3%) |
Jun 2021 | - | -$7.67 M(+86.0%) | -$41.62 M(+13.6%) |
Mar 2021 | - | -$4.12 M(-84.9%) | -$36.63 M(+5.2%) |
Dec 2020 | -$34.81 M(+238.3%) | - | - |
Dec 2020 | - | -$27.38 M(+1019.0%) | -$34.81 M(+368.7%) |
Sep 2020 | - | -$2.45 M(-8.5%) | -$7.43 M(+49.1%) |
Jun 2020 | - | -$2.67 M(+16.1%) | -$4.98 M(+116.1%) |
Mar 2020 | - | -$2.31 M | -$2.31 M |
Dec 2019 | -$10.29 M | - | - |
FAQ
- What is Vera Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Vera Therapeutics?
- What is Vera Therapeutics annual CFO year-on-year change?
- What is Vera Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Vera Therapeutics?
- What is Vera Therapeutics quarterly CFO year-on-year change?
- What is Vera Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Vera Therapeutics?
- What is Vera Therapeutics TTM CFO year-on-year change?
What is Vera Therapeutics annual cash flow from operations?
The current annual CFO of VERA is -$134.68 M
What is the all time high annual CFO for Vera Therapeutics?
Vera Therapeutics all-time high annual cash flow from operations is -$10.29 M
What is Vera Therapeutics annual CFO year-on-year change?
Over the past year, VERA annual cash flow from operations has changed by -$42.50 M (-46.10%)
What is Vera Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VERA is -$39.18 M
What is the all time high quarterly CFO for Vera Therapeutics?
Vera Therapeutics all-time high quarterly cash flow from operations is -$2.31 M
What is Vera Therapeutics quarterly CFO year-on-year change?
Over the past year, VERA quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Vera Therapeutics TTM cash flow from operations?
The current TTM CFO of VERA is -$134.68 M
What is the all time high TTM CFO for Vera Therapeutics?
Vera Therapeutics all-time high TTM cash flow from operations is -$2.31 M
What is Vera Therapeutics TTM CFO year-on-year change?
Over the past year, VERA TTM cash flow from operations has changed by $0.00 (0.00%)